Is It Too Late To Consider Xeris Biopharma Holdings (XERS) After Its 133% One-Year Surge? [Yahoo! Finance]
Xeris Biopharma Holdings, Inc. (XERS)
Last xeris biopharma holdings, inc. earnings: 3/11 06:00 am
Check Earnings Report
Company Research
Source: Yahoo! Finance
The stock last closed at US$7.93, with returns of 7.9% over the past week, 10.6% over the past month, 7.9% year to date, 133.2% over the past year, and a very large gain over three years. Recent coverage has focused on Xeris Biopharma Holdings as a US$ small cap in the pharmaceuticals and biotech space, with attention on its commercial product portfolio and liquidity position. This context helps explain why investors might be reassessing both the potential opportunity and the risks reflected in the share price. On Simply Wall St's 6 point valuation checklist, Xeris Biopharma Holdings scores a 3 out of 6 . Next, we will look at what traditional models say about that price, before finishing with a more complete way to think about valuation that ties everything together. Xeris Biopharma Holdings delivered 133.2% returns over the last year. See how this stacks up to the rest of the Pharmaceuticals industry. A Discounted Cash Flow, or DCF, model estimates what a company might be w
Show less
Read more
Impact Snapshot
Event Time:
XERS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
XERS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
XERS alerts
High impacting Xeris Biopharma Holdings, Inc. news events
Weekly update
A roundup of the hottest topics
XERS
News
- Xeris Biopharma (XERS) was upgraded by <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a> from "sell (d-)" to "hold (c-)".MarketBeat
- Xeris Biopharma: Undervalued Given The Potential Of Its Drug Portfolio [Seeking Alpha]Seeking Alpha
- Xeris Biopharma Holdings Inc (XERS) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... [Yahoo! Finance]Yahoo! Finance
- Xeris Biopharma Holdings, Inc. Q4 2025 Earnings Call Summary [Yahoo! Finance]Yahoo! Finance
- Xeris Biopharma (XERS) had its "buy" rating reaffirmed by HC Wainwright. They now have a $10.00 price target on the stock.MarketBeat
XERS
Earnings
- 3/2/26 - Beat
XERS
Sec Filings
- 3/5/26 - Form 4
- 3/4/26 - Form 4
- 3/2/26 - Form 144
- XERS's page on the SEC website